RNU6-725P

Across TCGA pan-cancer cohorts, RNU6-725P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-725P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-725P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-725P expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

OV, COAD, and READ are the cancer types where RNU6-725P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	All	0.540	0.711	<.001	108	view →
COAD	OS	Tertile	II,III,IV	0.232	0.793	<.001	102	view →
READ	OS	Tertile	All	0.166	0.830	<.001	72	view →
DLBC	OS	Tertile	II,III,IV	0.115	0.839	<.001	63	view →
MESO	OS	Tertile	All	0.052	0.528	.016	54	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
LGG	OS	Tertile	All	0.512	0.822	<.001	39	view →
GBM	DFS	Tertile	All	0.140	0.270	<.001	36	view →
KIRC	DFS	Quartile	All	0.540	0.656	.005	35	view →
ESCA	OS	Quartile	III,IV	0.362	0.633	.009	22	view →
THCA	OS	Tertile	IV	0.579	0.987	<.001	18	view →
HNSC	DFS	Quartile	III,IV	0.456	0.299	.026	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-725P–OV (OS)

Open the OV breakdown →